SHENZHEN, China, July 25, 2024 /PRNewswire/ -- On July
18, BGI Genomics announced the opening of the Astana Genetic
Center (AGC), a world-class genetic laboratory in Astana,
Kazakhstan, in partnership with
Technopark Biogen. This collaboration aims at utilizing
cutting-edge technology to facilitate early disease diagnosis and
advance preventive medicine in Kazakhstan, as well as other Central Asian
countries.
The opening ceremony of AGC laboratory was attended by Kunsulu
Zakariya, Advisor to the President of the Republic of Kazakhstan on Science and Innovation, Akmaral
Alnazarova, the Minister of Health of the Republic of Kazakhstan, Zholdykhan Sanat, CEO of the
National Agency for Innovation Development "QazInnovations", Dr.
Yin Ye, CEO of BGI Group, parent
company of BGI Genomics, Dr. Li
Ning, deputy general manager of BGI Genomics and other
officials/business leaders from Kazakhstan.
The AGC laboratory, located at the National Center for
Biotechnology of Kazakhstan, is
equipped with the latest DNA sequencing and genomic data analysis
equipment. It aims to serve as a vital center for conducting tests
that will enhance the health of the Kazakhstani population.
This landmark event heralded a new era in the field of genetic
testing for reproductive health and oncology, providing the
citizens of Kazakhstan with
advanced capabilities for NIFTY ® the non-invasive prenatal
testing, NOVA™ Newborn Genetic Screening (including screening for
metabolic disease), PGT-A, the preimplantation genetic testing
for aneuploidies, colorectal cancer screening, and other
services.
The laboratory will collaborate closely with leading Kazakh
companies, implement the advanced genetic tests, and exchange
expertise with colleagues in Kazakhstan and other Central Asian countries.
The AGC is envisioned to become a key node in the network of
advanced genetic testing, opening new horizons for the development
of the healthcare sector in the Republic of Kazakhstan.
Kazakh officials present at the laboratory's opening expressed
confidence that this important event would mark a new step in
genetic testing and contribute to improving the health and quality
of life of the Kazakhstani population.
About BGI Genomics
BGI Genomics, headquartered in Shenzhen, China, is the world's leading
integrated solutions provider of precision medicine. Its services
cover more than 100 countries and regions, involving more than
2,300 medical institutions and 10,000 employees worldwide. In
July 2017, as a subsidiary of BGI
Group, BGI Genomics (300676.SZ) officially began trading on the
Shenzhen Stock Exchange.
Photo - https://mma.prnewswire.com/media/2469085/1.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/a-new-era-for-healthcare-in-kazakhstan-unveiling-astana-genetic-center-cutting-edge-genetic-testing-laboratory-302206569.html